These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4053717)

  • 1. Prolonged toxicity following massive ingestion of sustained-release theophylline preparation.
    Corser BC; Youngs C; Baughman RP
    Chest; 1985 Nov; 88(5):749-50. PubMed ID: 4053717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-bowel irrigation as adjunctive treatment for sustained-release theophylline overdose.
    Burkhart KK; Wuerz RC; Donovan JW
    Ann Emerg Med; 1992 Nov; 21(11):1316-20. PubMed ID: 1416325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation.
    Bernstein G; Jehle D; Bernaski E; Braen GR
    Ann Emerg Med; 1992 Nov; 21(11):1388-90. PubMed ID: 1416337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of theophylline toxicity with oral activated charcoal.
    Sessler CN; Glauser FL; Cooper KR
    Chest; 1985 Mar; 87(3):325-9. PubMed ID: 3971756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of vomiting associated with acute sustained release theophylline poisoning: implications for management with oral activated charcoal.
    Amitai Y; Lovejoy FH
    J Toxicol Clin Toxicol; 1987; 25(7):539-54. PubMed ID: 2895817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of theophylline toxicity with oral activated charcoal.
    True RJ; Berman JM; Mahutte CK
    Crit Care Med; 1984 Feb; 12(2):113-4. PubMed ID: 6697727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA; Glucksman E; Henry JA
    Hum Exp Toxicol; 1995 Feb; 14(2):170-4. PubMed ID: 7779441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal.
    Lim DT; Singh P; Nourtsis S; Dela Cruz R
    Ann Emerg Med; 1986 Nov; 15(11):1303-7. PubMed ID: 3777587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe neurologic complications secondary to poisoning by slow-release theophylline].
    Carpentier F; Pison C; Barnoud D; Guignier M; Paramelle B
    Rev Pneumol Clin; 1987; 43(4):182-5. PubMed ID: 3671969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive theophylline intoxication: effects of charcoal haemoperfusion on plasma and erythrocyte theophylline concentrations.
    van Kesteren RG; van Dijk A; Klein SW; van Heijst AN
    Hum Toxicol; 1985 Mar; 4(2):127-34. PubMed ID: 4007877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
    Biagini L; Zamora P; Chávez H; Saavedra I
    Rev Med Chil; 1990 Nov; 118(11):1241-6. PubMed ID: 2152650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-line hemodialysis and hemoperfusion in a girl intoxicated by theophylline.
    Stegmayr BG
    Acta Med Scand; 1988; 223(6):565-7. PubMed ID: 3389209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma theophylline concentrations following the oral administration of microcrystalline theophylline and a new sustained-release theophylline preparation to normal subjects.
    Russell CJ; Elwood RK; Kinney C; McDevitt DG
    Eur J Clin Pharmacol; 1980 Oct; 18(4):351-4. PubMed ID: 7439257
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid rise in serum theophylline concentration after overdose with sustained release theophylline.
    Henderson A; Pond SM
    Med J Aust; 1992 Sep; 157(5):354, 356. PubMed ID: 1435489
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation.
    al-Shareef AH; Buss DC; Allen EM; Routledge PA
    Hum Exp Toxicol; 1990 May; 9(3):179-82. PubMed ID: 2375885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent haemodialysis and sustained low-efficiency dialysis (SLED) for acute theophylline toxicity.
    Fisher J; Graudins A
    J Med Toxicol; 2015 Sep; 11(3):359-63. PubMed ID: 25794556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity.
    Amitai Y; Yeung AC; Moye J; Lovejoy FH
    Ann Intern Med; 1986 Sep; 105(3):386-7. PubMed ID: 3740677
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline.
    Goldberg MJ; Spector R; Park GD; Johnson GF; Roberts P
    Clin Pharmacol Ther; 1987 Jan; 41(1):108-11. PubMed ID: 3802699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.